Diagnostic Procedure – Page 7

Novartis to Revise CRO Partnerships Amidst US Senate Bill Scrutiny

2 years ago talkbio0Tagged Chinese Language, CRO, Drug Industry, Novartis, Partnership, regulatory, Relationships, Revisions, Senate

Novartis, CRO relationships, US Senate bill, Chinese companies, pharmaceutical industry, regulatory changes, partnership revisions

BenevolentAI Downsizes Operations, Cuts 30% of Workforce Amidst Funding Challenges

2 years ago talkbio0Tagged AI, Artificial Intelligence, BenevolentAI, Drug Discovery, GTPase-Activating Proteins, research

BenevolentAI, layoffs, workforce reduction, funding gap, US site closure, AI research, drug discovery

BenevolentAI Announces Significant Restructuring with Workforce Reduction and US Office Closure

2 years ago talkbio0Tagged Artificial Intelligence, BenevolentAI, Biotechnology, Drug Discovery, Office Closure, reSET (device), restructuring

BenevolentAI, restructuring, workforce reduction, US office closure, reset, artificial intelligence, biotechnology, drug discovery

Shimadzu Corporation Expands US Presence with Three New R&D Centers for Pharmaceutical Growth

2 years ago talkbio0Tagged business growth, Central, Corporation, Drug Industry, expansion, innovation, Shimadzu, Technology, U.S.

Shimadzu Corporation, R&D centers, US expansion, pharmaceutical industry, business growth, innovation, technology.

Novartis Reevaluates Chinese Contractor Ties Amidst US Biosecurity Concerns

2 years ago talkbio0Tagged Biosecurity, CFO, Chinese contractors, Novartis, Relationships, U.S.

Novartis, Chinese contractors, US biosecurity, CFO, review, relationships, crackdown

Revolutionizing Women’s Healthcare: GE HealthCare Unveils AI-Driven, Voice-Activated Ultrasound Machines

2 years ago talkbio0Tagged AI-powered, Diagnostic Imaging, Discipline of obstetrics, Gynecology, Health care facility, healthcare innovation, medical technology, ultrasound machines, voice-activated, women 's health

GE HealthCare, voice-activated, AI-powered, ultrasound machines, women’s health, healthcare innovation, medical technology, diagnostic imaging, obstetrics, gynecology.

Sanofi Restructures US Commercial Vaccine Group Amid Cost-Saving Campaign

2 years ago talkbio0Tagged Commercial Vaccine, Cost-Savings Campaign, Effectiveness, Efficiency, Employee, Evolving, Market, Optimization, Outplacement, restructuring, sanofi, streamlined strategic sales, Structure, Vaccines

Sanofi, Restructuring, US Commercial Vaccine Group, Cost-Savings Campaign, Streamlined Strategic Sales Structure, Evolving Vaccine Market, Optimization for Efficiency and Effectiveness, Employee Support and Outplacement Assistance

Roche’s Ocrevus Demonstrates Near-Complete Reduction of Relapse and Lesions in Multiple Sclerosis

2 years ago talkbio0Tagged Clinical, Lesion, Magnetic Resonance Imaging, Multiple Sclerosis, Multiple Sclerosis, Ocrevus, Relapse, Roche (company)

Ocrevus, Roche, Multiple Sclerosis (MS), Relapse reduction, Lesion reduction, Clinical and MRI measures

Record-Breaking 323 Medications in Active Shortage in US, ASHP Reports

2 years ago talkbio0Tagged Active shortages, Adderall, American Society of Health-System Pharmacists, Antineoplastic Agents, ASHP, Attention deficit hyperactivity disorder, Drug Enforcement Administration, Drug shortages, Drug supply chains, Generic sterile injectable medications, Policy, Recommendation, Record-high

Drug shortages, US, Record-high, American Society of Health-System Pharmacists (ASHP), 323 medications, Active shortages, Generic sterile injectable medications, Cancer chemotherapy drugs, ADHD medications, Adderall, Drug Enforcement Administration (DEA), Drug supply chains, Policy recommendations

Basilea Secures FDA Approval for Zevtera to Treat Three Types of Bacterial Infections

2 years ago talkbio0Tagged ABSSSI, Acute bacterial skin, Approved, Bacteremia due to Staphylococcus aureus, Basilea Pharmaceutica, CABP, ceftobiprole, Community-acquired bacterial pneumonia, designations, exclusivity, Priority Review, QIDP, Qualified Infectious Disease Product, skin structure infections, Track/, United States Food and Drug Administration, year, Zevtera

Basilea Pharmaceutica, Zevtera (ceftobiprole), FDA approval, Acute bacterial skin and skin structure infections (ABSSSI), Staphylococcus aureus bacteremia (SAB), Community-acquired bacterial pneumonia (CABP), Qualified Infectious Disease Product (QIDP) status, Priority Review/ Fast Track/ and QIDP designations, Ten years of exclusivity in the US